Mark As Not Viewed
Waukesha Storefront and Facade Grant
City of Waukesha
ABOUT THE GRANT
Funded through the Community Development Block Grant (CDBG), this program offers matching grants for eligible improvements to commercial properties in Downtown Waukesha and nearby central city areas.
Tracking grants is our job
Sign up for The Grant Brief to get our latest grants every Tuesday. One email, zero fluff.
NOTES
We haven't added commentary on this grant yet. In the meantime, the fundor's website (linkeded above) is the best source for application details and eligibility specifics.
Not the right grant for you?
Other Grants
Bethlehem Microenterprise Grant
Town of Bethlehem
The Bethlehem Microenterprise Grant Program provides Bethlehem, New York microenterprises with grants ranging from $5,000 to $35,000 to support new and existing small businesses with five or fewer employees. Administered by the Town of Bethlehem's Department of Economic Development and Planning and funded through the New York State Office of Homes and Community Renewal's Community Development Block Grant (CDBG) program, the grant is designed to help businesses purchase capital goods (including machinery, furniture, fixtures, equipment, and software) or provide working capital to support business operations. Eligible applicants must be a private for-profit business (corporation, partnership, or sole proprietorship) located or planning to locate within the Town of Bethlehem, with five or fewer employees including the owner. Because the program is funded with federal CDBG dollars, all grants must meet a national objective: businesses must either be owned by a low-to-moderate income (LMI) individual or create at least one new full-time-equivalent job available to LMI persons within a 24-month grant period. Applicants must also contribute a minimum 10% cash equity match, complete an approved Entrepreneurial Training Program before receiving funds, and at least 50% of grant funds in each round are reserved for start-up businesses (those operating less than six months at the time of application). Grant funds cannot be used for real estate purchases, debt repayment, façade or interior construction, or any investment outside the scope of the business. Previous recipients may reapply, with combined first- and second-time awards capped at $45,000.
Experimental Approaches to Advance Drug Repositioning and Combination Therapy for Alzheimer's and Dementia
National Institutes of Health
This Notice of Funding Opportunity (NOFO) invites applications that propose to use mouse models to conduct rigorous preclinical testing of drugs or drug combinations currently used for other conditions, as well as investigational drugs at various stages of clinical development, predicted to be efficacious in AD/ADRD. This initiative will also support preclinical testing of repurposable or investigational drug candidates in combination with non-pharmacologic interventions leading to robust translational outcomes. The central goal is to establish robust proof of concept that will enable rational drug repurposing and combination therapy development for the treatment and prevention of AD/ADRD.
Brentwood Economic Development Grant
City of Brentwood
The City of Brentwood sets aside 20% of its business operating tax revenue for “economic development, with the explicit purpose of business promotion and institutional advertisement for the City of Brentwood.” As part of this effort, each year, the City offers reimbursement grants for local marketing; events; and business development projectsthrough the Economic Development Grant Program. Any organization or business can apply, if they have a current Brentwood Business License or are exempt from the Business License Requirement. Non‐profit and/or tax‐exempt organizations are also eligible, provided they submit proof of active status from the Secretary of State.
LiftFund Disaster Relief Program
LiftFund
The LiftFund Disaster Relief Program provides small businesses recovering from natural disasters with a combination of grants, 0% interest loans, and hands-on technical assistance to help them rebuild and reopen quickly. Administered by LiftFund — a San Antonio-based nonprofit Community Development Financial Institution (CDFI) that has supported disaster recovery efforts since Hurricane Katrina — the program operates through individual sub-programs created in response to specific disasters, each developed in partnership with local foundations, donors, and community organizations. Because each sub-program is uniquely designed around the conditions and needs of an affected region, the specific grant amounts, loan terms, eligibility criteria, and funding pathways vary by disaster, but each program is typically built around the same core components: direct grant funding to help cover rebuilding expenses, replacement costs for damaged equipment, and general operating expenses; 0% interest loans with flexible terms, waived origination fees, and flexible collateral requirements to bridge gaps that grants alone cannot cover; and technical assistance such as one-on-one coaching, workshops, and help navigating the application process. Applicants are generally evaluated on both physical damage and economic injury caused by the disaster, and businesses that did not sustain direct property damage may still qualify if they experienced a measurable decline in revenue. Recent active sub-programs have served businesses in Kerr County and San Angelo, Texas, as well as the broader Hill Country region. Interested business owners should check LiftFund's Special Programs page for the disaster relief programs currently accepting applications.
Planning for Product Development Strategy - HIV
National Institutes of Health
The purpose of this Notice of Funding Opportunity (NOFO) is to support the development of a comprehensive and well-defined product development strategy for next-generation treatments for HIV and HIV-associated comorbidities, coinfections and complication and preventive strategies for HIV, as well as facilitating the translation of research findings into drug products that enables submission of an Investigational New Drug (IND) application to the FDA.